LDR | |
01322cam a2200277 a 4500 |
001 |
|
010598916 |
003 |
|
MiAaHDL |
005 |
|
20101005000000.0 |
006 |
|
m d |
007 |
|
cr bn ---auaua |
008 |
|
050610s2003 mduab f100 0 eng d |
035 |
⊔ |
⊔ |
‡asdr-nwu4172851
|
040 |
⊔ |
⊔ |
‡aIEN-M
‡cIEN-M
|
043 |
⊔ |
⊔ |
‡an-us---
|
060 |
⊔ |
4 |
‡aWM 270
‡bE64d 2002b
|
245 |
0 |
0 |
‡aEpidemiologic trends in drug abuse, December 2002 /
‡cCommunity Epidemiology Work Group.
|
246 |
1 |
7 |
‡aCEWG December 2002
|
260 |
⊔ |
⊔ |
‡aBethesda, Md. :
‡bNational Institutes of Health, Division of Epidemiology, Services and Prevention Research, National Institute on Drug Abuse,
‡c2003.
|
300 |
⊔ |
⊔ |
‡av. :
‡bill., maps ;
‡c28 cm.
|
490 |
⊔ |
0 |
‡aNIH publication ;
‡vno. 03-5365
|
500 |
⊔ |
⊔ |
‡a"Printed August 2003"--Verso t. p.
|
500 |
⊔ |
⊔ |
‡a"The 53rd meeting of the CEWG was held in Miami, Florida, December 10-13, 2002."--p. iii.
|
505 |
1 |
⊔ |
‡av. 2. Proceedings.
|
538 |
⊔ |
⊔ |
‡aMode of access: Internet.
|
650 |
⊔ |
2 |
‡aSubstance-Related Disorders
‡xepidemiology.
|
651 |
⊔ |
2 |
‡aUnited States.
|
655 |
⊔ |
7 |
‡aCongresses.
‡2mesh
|
710 |
2 |
⊔ |
‡aNational Institute on Drug Abuse.
‡bDivision of Epidemiology and Prevention Research.
|
710 |
2 |
⊔ |
‡aNational Institute on Drug Abuse.
‡bCommunity Epidemiology Work Group.
|
710 |
2 |
⊔ |
‡aNational Institute on Drug Abuse.
‡bCommunity Epidemiology Work Group.
‡bMeeting
‡n(53rd :
‡d2002 :
‡cMiami, Fla.).
|
CID |
⊔ |
⊔ |
‡a010598916
|
DAT |
0 |
⊔ |
‡a20050610101029.0
‡b20101005000000.0
|
DAT |
1 |
⊔ |
‡a20120815041604.0
‡b2023-09-08T17:45:52Z
|
DAT |
2 |
⊔ |
‡a2023-09-08T17:30:02Z
|
CAT |
⊔ |
⊔ |
‡aSDR-NWU
‡dUNKNOWN
‡lloader.pl-001-001
|
FMT |
⊔ |
⊔ |
‡aBK
|
HOL |
⊔ |
⊔ |
‡0sdr-nwu4172851
‡aien
‡bSDR
‡cNWU
‡pien.35557000121846
‡sIEN
‡zv.2
‡14172851
|
974 |
⊔ |
⊔ |
‡bIEN
‡cNWU
‡d20230908
‡sgoogle
‡uien.35557000121846
‡zv.2
‡y2003
‡rpd
‡qbib
‡tUS fed doc
|